1. Home
  2. CWBC vs CRVS Comparison

CWBC vs CRVS Comparison

Compare CWBC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community West Bancshares

CWBC

Community West Bancshares

N/A

Current Price

$25.58

Market Cap

704.3M

Sector

Finance

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$10.61

Market Cap

843.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CWBC
CRVS
Founded
1989
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
704.3M
843.7M
IPO Year
2000
2016

Fundamental Metrics

Financial Performance
Metric
CWBC
CRVS
Price
$25.58
$10.61
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$30.10
★ $31.50
AVG Volume (30 Days)
161.7K
★ 927.7K
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 1.85%
N/A
EPS Growth
★ 344.44
48.04
EPS
★ 0.91
N/A
Revenue
N/A
N/A
Revenue This Year
$42.29
N/A
Revenue Next Year
$14.59
N/A
P/E Ratio
$28.45
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.12
$6.39
52 Week High
$28.17
$26.95

Technical Indicators

Market Signals
Indicator
CWBC
CRVS
Relative Strength Index (RSI) 44.59 50.16
Support Level $25.05 $9.40
Resistance Level $26.45 $10.81
Average True Range (ATR) 0.63 0.67
MACD -0.02 0.20
Stochastic Oscillator 9.84 52.73

Price Performance

Historical Comparison
CWBC
CRVS

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments. The company has one reportable segment: Banking operations. Loans and leases, investment securities, interest-bearing deposits and non-interest income provide the revenues of the banking operation.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: